Meet Us at TERMIS EU 2025 in Freiburg! | Booth 22

from 20 to 23 May 2025.

Join us from 20–23 May 2025 at the TERMIS EU Conference at Messe Freiburg, Germany. Visit us at Booth 22 to discover the latest innovations in regenerative medicine and tissue engineering.

We are proud to announce that two of our researchers from Geneva, Switzerland, will be presenting their latest findings:

Dr Sarah Berndt

Dr Sarah Berndt

POSTER ID 723

Optimizing the regenerative potential of vaginal fibroblasts: the role of autologous platelet-rich plasma and hyaluronic acid in vitro

Thursday, 22 May, 15:30 – 15:30 CEST

Part of session: Translation – Personalized medicine applications

Dr. Axel Tollance

Dr. Axel Tollance

POSTER ID 1315

Platelet-rich plasma (PRP) induces a metabolic shift toward fatty acid oxidation in human primary myoblasts

Thursday, 22 May | 15:30 CEST

Part of session: Stem Cells – Differentiation, migration, activation

Related Content

ANGIOGENESIS, A KEY STAGE OF TISSUE REGENERATION, IS MODULATED BY PLATELETS.

Sarah BERNDT PhD1 | Gilles CARPENTIER2 | Axel TOLLANCE PhD1,3 | Antoine TURZI1

About Us

Since 2003, Regen Lab SA has specialized in designing and manufacturing high-quality medical devices for cell therapies and the preparation of autologous platelet-rich plasma (PRP) from the patient's own blood for bedside procedures.

More

Milestones

2003 - Foundation
2010 - RegenKit first approval in bone graft
2013 - A new state-of-theart laboratory in Lausanne
2014 - Cellular Matrix first approval
2015 - Launch of Cellular Matrix in Europe

More

Vision

Founded in 2003, Regen Lab has become a global reference thanks to its commitment to innovation, quality, and the effectiveness of its therapeutic solutions. Here’s how we have transformed the medical landscape over the past two decades.

More

RegenPRP™

RegenPRP™ is a medical treatment that uses platelet-rich plasma from the patient's own blood to enhance and tissue regeneration.

More

RegenPRP™ - HA

RegenPRP™ - HA combination is an innovative treatment combining platelet-rich plasma (PRP) and hyaluronic acid to improve tissue regeneration and healing.

More

RegenPRP™ - ATS

RegenPRP™ combined with ATS (Autologous Thrombin Serum) is an advanced approach to tissue regeneration that uses autologous thrombin-enriched platelet-rich plasma (PRP) to maximise healing effects.

More

RegenExtracell®

RegenExtracell is an innovative tissue regeneration treatment using an extracellular matrix enriched with platelet-rich plasma (PRP).

More

Hyaluronic Acid

Coming Soon

Regulatory

Manufacturers of medical devices based outside the EU must designate an Authorized Representative (EC-REP) established within the EU in order to meet the CE requirements for placing medical devices on the EU market.

More

Quality Management

Regen Lab Quality System Management ensures the consistency of our products quality in total GMP compliance.

Our production facility rooms atmosphere is monitored to satisfy non-pyrogenic medical devices manufacturing.

More

Patents

As a leader in the PRP&HA regenerative field and as an innovation-driven company, Regen Lab SA has devoted important resources since 2004 to put on the market pioneering and diversified products constituting a complete set of tools/technologies for the medical community.

More